4//SEC Filing
Burrows Scott L 4
Accession 0001636282-26-000004
CIK 0001636282other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:27 PM ET
Size
5.6 KB
Accession
0001636282-26-000004
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+140,000→ 140,000 totalExercise: $30.61Exp: 2036-01-09→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 140,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact|2026-01-13
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001853327
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 9:27 PM ET
- Size
- 5.6 KB